NCT06236061 2026-01-13
Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy
Novartis
Phase 3 Completed
Novartis
St. Jude Children's Research Hospital
Novartis
Boryung Pharmaceutical Co., Ltd
Scripps Translational Science Institute
Takeda
University of Pavia